dihexa human clinical trials published Research Peptide | Laboratory Grade Specification:15mg Anesthetics Novo Nordisk's stock drops

dihexa human clinical trials published Research Peptide | Laboratory Grade Specification:15mg Anesthetics Novo Nordisk's stock drops

Novo Nordisk's stock drops despite CagriSema hitting goal of Phase III trial - Clinical Trials Arena

All content is developed by SES in collaboration with an expert steering committee

Anesthetics

Specification:15mg

Finerenone, a novel selective mineralocorticoid receptor antagonist (MRA), has manifested both cardiovascular and kidney protection confirmed by two phase III trials, Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD) (145) and Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) (146) together with FIDELITY pooled analysis (147)